Status:
RECRUITING
The Role of Multimodality Imaging in Left Atrial Appendage Closure
Lead Sponsor:
Hungarian Institute of Cardiology
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the present prospective, randomized single-centre study is to examine the success rate, safety, overall preoperative and operative burden and long-time outcome of percutaneous left atrial a...
Detailed Description
Left atrial appendage closure (LAAC) is an increasingly used non-pharmacologic strategy to prevent stroke in patients with atrial fibrillation who have absolute or relative contraindications to long-t...
Eligibility Criteria
Inclusion
- Patients, who have clinical indication to LAAC and are undergoing percutaneous LAAC procedure in Gottsegen National Cardiovascular Center from 10.03.2021 to 31.12.2025
- Age above 18 years
- Informed consent
- Legal capacity
Exclusion
- Age under 18 years
- Pregnancy
- Incapacitation
- Absence of consent
- Esophageal stenosis or diverticulum
- Active esophageal bleeding
- CT-contrast agent allergy
- Severe chronic kidney disease (GFR\<15 ml/min/1,73 m2)
- Appendage thrombus (mobile/with significant embolic risk)
- Life expectancy shorter than 12 months
- Active infection
- Significant mitral valve stenosis
- Mechanical heart valve
- Open heart surgery is indicated
Key Trial Info
Start Date :
November 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2029
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04800913
Start Date
November 8 2021
End Date
December 1 2029
Last Update
October 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hungarian Institute of Cardiology (Gottsegen National Cardiovascular Center)
Budapest, Hungary, 1096